SCHEMBL29930372

SCHEMBL29930372

Brc1cnc2[nH]nc(-c3ccsc3)c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 5/20 0.60
CYP2A6 P11509 2/20 0.46
MAPKAPK2 P49137 1/20 0.41
CDK8 P49336 2/20 0.39
DYRK1A Q13627 5/20 0.38
CDK5 Q00535 3/20 0.38
MAP4K4 O95819 3/20 0.38
FGFR1 P11362 3/20 0.38
CLK2 P49760 3/20 0.38
MAP4K2 Q12851 3/20 0.38
AURKB Q96GD4 3/20 0.38
CLK4 Q9HAZ1 3/20 0.38
AURKA O14965 2/20 0.38
JAK2 O60674 2/20 0.38
IGF1R P08069 2/20 0.38
FLT1 P17948 2/20 0.38
KDR P35968 2/20 0.38
JAK3 P52333 2/20 0.38
LIMK1 P53667 2/20 0.38
NTRK2 Q16620 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28559332 0.80 DYRK1A (0.44) DYRK1BCDK8DYRK1ACDK5MAP4K4
SCHEMBL5061384 0.78 DYRK1A (0.57) DYRK1BCDK8DYRK1ACDK5MAP4K4
SCHEMBL28553364 0.78 DYRK1B (0.39) DYRK1BCDK8DYRK1ACDK5MAP4K4
SCHEMBL28556801 0.77 IDO1 (0.44) DYRK1BDYRK1ACDK5MAP4K4FGFR1
SCHEMBL29930770 0.76 DYRK1B (0.58) DYRK1BMAPKAPK2CDK8DYRK1ACDK5
SCHEMBL28560103 0.75 LRRK2 (0.48) DYRK1BCDK8DYRK1ACDK5MAP4K4
SCHEMBL28553148 0.75 DYRK1B (0.56) DYRK1BCDK8DYRK1ACDK5MAP4K4
SCHEMBL7943191 0.73 PIM1 (0.42) DYRK1BCDK8DYRK1ACDK5MAP4K4
SCHEMBL38652158 0.72 AURKA (0.48) DYRK1BDYRK1ACDK5MAP4K4FGFR1
SCHEMBL28562998 0.72 DYRK1B (0.61) DYRK1BDYRK1ASYKGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed